Invesco’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Buy |
618,835
+117,617
| +23% | +$6.47M | 0.01% | 1212 |
|
|
2025
Q1 | $35.4M | Sell |
501,218
-3,563
| -0.7% | -$252K | 0.01% | 1166 |
|
|
2024
Q4 | $33.2M | Sell |
504,781
-38,291
| -7% | -$2.52M | 0.01% | 1235 |
|
|
2024
Q3 | $38.2M | Buy |
543,072
+5,622
| +1% | +$395K | 0.01% | 1154 |
|
|
2024
Q2 | $44.2M | Buy |
537,450
+123,433
| +30% | +$10.2M | 0.01% | 1062 |
|
|
2024
Q1 | $36.2M | Buy |
414,017
+17,912
| +5% | +$1.56M | 0.01% | 1180 |
|
|
2023
Q4 | $38.2M | Sell |
396,105
-52,512
| -12% | -$5.06M | 0.01% | 1122 |
|
|
2023
Q3 | $39.7M | Sell |
448,617
-535,553
| -54% | -$47.4M | 0.01% | 1048 |
|
|
2023
Q2 | $85.3M | Sell |
984,170
-832,840
| -46% | -$72.2M | 0.02% | 766 |
|
|
2023
Q1 | $177M | Sell |
1,817,010
-18,051
| -1% | -$1.76M | 0.05% | 523 |
|
|
2022
Q4 | $190M | Buy |
1,835,061
+1,430,955
| +354% | +$148M | 0.06% | 485 |
|
|
2022
Q3 | $34.3M | Buy |
404,106
+107,568
| +36% | +$9.12M | 0.01% | 1047 |
|
|
2022
Q2 | $24.6M | Buy |
296,538
+6,849
| +2% | +$568K | 0.01% | 1248 |
|
|
2022
Q1 | $22.3M | Buy |
289,689
+6,266
| +2% | +$483K | 0.01% | 1441 |
|
|
2021
Q4 | $25M | Sell |
283,423
-6,072
| -2% | -$536K | 0.01% | 1410 |
|
|
2021
Q3 | $22.4M | Buy |
289,495
+13,676
| +5% | +$1.06M | 0.01% | 1492 |
|
|
2021
Q2 | $23M | Sell |
275,819
-129,362
| -32% | -$10.8M | 0.01% | 1529 |
|
|
2021
Q1 | $30.6M | Buy |
405,181
+86,222
| +27% | +$6.51M | 0.01% | 1299 |
|
|
2020
Q4 | $28M | Sell |
318,959
-267,701
| -46% | -$23.5M | 0.01% | 1263 |
|
|
2020
Q3 | $44.6M | Buy |
586,660
+45,748
| +8% | +$3.48M | 0.02% | 983 |
|
|
2020
Q2 | $66.7M | Buy |
540,912
+12,772
| +2% | +$1.58M | 0.02% | 781 |
|
|
2020
Q1 | $44.6M | Sell |
528,140
-91,163
| -15% | -$7.7M | 0.02% | 854 |
|
|
2019
Q4 | $52.4M | Sell |
619,303
-1,628,859
| -72% | -$138M | 0.02% | 999 |
|
|
2019
Q3 | $152M | Sell |
2,248,162
-597,674
| -21% | -$40.3M | 0.04% | 512 |
|
|
2019
Q2 | $244M | Sell |
2,845,836
-622,286
| -18% | -$53.3M | 0.06% | 361 |
|
|
2019
Q1 | $308M | Buy |
3,468,122
+153,073
| +5% | +$13.6M | 0.1% | 227 |
|
|
2018
Q4 | $282M | Buy |
3,315,049
+17,892
| +0.5% | +$1.52M | 0.11% | 216 |
|
|
2018
Q3 | $320M | Sell |
3,297,157
-11,306
| -0.3% | -$1.1M | 0.1% | 215 |
|
|
2018
Q2 | $312M | Sell |
3,308,463
-883,153
| -21% | -$83.2M | 0.1% | 215 |
|
|
2018
Q1 | $340M | Sell |
4,191,616
-322,025
| -7% | -$26.1M | 0.13% | 187 |
|
|
2017
Q4 | $402M | Buy |
4,513,641
+24,250
| +0.5% | +$2.16M | 0.15% | 162 |
|
|
2017
Q3 | $418M | Buy |
4,489,391
+285,475
| +7% | +$26.6M | 0.15% | 153 |
|
|
2017
Q2 | $382M | Buy |
4,203,916
+570,718
| +16% | +$51.8M | 0.12% | 191 |
|
|
2017
Q1 | $319M | Buy |
3,633,198
+245,430
| +7% | +$21.5M | 0.1% | 219 |
|
|
2016
Q4 | $281M | Buy |
3,387,768
+328,400
| +11% | +$27.2M | 0.09% | 245 |
|
|
2016
Q3 | $283M | Buy |
3,059,368
+701,506
| +30% | +$64.9M | 0.1% | 233 |
|
|
2016
Q2 | $183M | Sell |
2,357,862
-106,783
| -4% | -$8.31M | 0.07% | 312 |
|
|
2016
Q1 | $203M | Sell |
2,464,645
-175,658
| -7% | -$14.5M | 0.08% | 278 |
|
|
2015
Q4 | $277M | Buy |
2,640,303
+175,626
| +7% | +$18.4M | 0.11% | 209 |
|
|
2015
Q3 | $260M | Buy |
2,464,677
+1,326,148
| +116% | +$140M | 0.11% | 215 |
|
|
2015
Q2 | $156M | Buy |
1,138,529
+249,445
| +28% | +$34.1M | 0.06% | 372 |
|
|
2015
Q1 | $111M | Buy |
889,084
+847
| +0.1% | +$106K | 0.04% | 478 |
|
|
2014
Q4 | $80.3M | Buy |
888,237
+387,805
| +77% | +$35.1M | 0.03% | 590 |
|
|
2014
Q3 | $36.1M | Sell |
500,432
-630
| -0.1% | -$45.5K | 0.01% | 946 |
|
|
2014
Q2 | $31.2M | Sell |
501,062
-734,907
| -59% | -$45.7M | 0.01% | 1026 |
|
|
2014
Q1 | $84.3M | Sell |
1,235,969
-639,405
| -34% | -$43.6M | 0.03% | 556 |
|
|
2013
Q4 | $132M | Sell |
1,875,374
-125,663
| -6% | -$8.84M | 0.05% | 426 |
|
|
2013
Q3 | $144M | Sell |
2,001,037
-130,116
| -6% | -$9.39M | 0.06% | 360 |
|
|
2013
Q2 | $119M | Buy |
+2,131,153
| New | +$119M | 0.06% | 381 |
|